ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for...

EOFY Sale 2025: Slash Winter Power Bills with BLUETTI's Smart Energy Solutions

EOFY Sale 2025: Slash Winter Power Bills with BLUETTI's Smart Energy Solutions

Offers on Portable Power Stations, Solar Panels, and Home Backup Systems from June 1–30 SYDNEY, June 1, 2025 /PRNewswire/ -- As energy use climbs during the colder months, BLUETTI is launching its End of Financial Year (EOFY) Sale to help...

The MarTech Summit Manila, 2 July 2025 at Fairmont Makati

The MarTech Summit Manila, 2 July 2025 at Fairmont Makati

MANILA, Philippines, May 14, 2025 /PRNewswire/ -- The MarTech Summit Manila is coming to the Philippines on 2 July 2025 at the prestigious Fairmont Makati! We're thrilled to return to Manila — a key hub in Southeast Asia's digital economy — bringing...

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology

Funding is part of the call for proposals "Innovations in Biotherapies and Bioproduction," coordinated by the Health Innovation Agency under France 2030 strategy, operated on behalf of the French government by Bpifrance PARIS, May 13, 2025...

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy

– Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund – Proceeds will support the Phase 1/2 clinical trial of lead...

APSEZ acquires 50 MTPA capacity NQXT Australia, accelerating path to 1 billion tonnes p.a. by 2030

APSEZ acquires 50 MTPA capacity NQXT Australia, accelerating path to 1 billion tonnes p.a. by 2030

NQXT is a highly efficient and cash generating asset that will consolidate APSEZ's presence along the East-West trade corridor, in line with its global expansion strategy Cargo Increase EBITDA Increase EV/ EBITDA Multiple 35 MMT NQXT throughput -...

Street Fighter 6 Joins HERO ESPORTS Asian Champions League: Two Spots Available for Esports World Cup

Street Fighter 6 Joins HERO ESPORTS Asian Champions League: Two Spots Available for Esports World Cup

SHANGHAI, March 19, 2025 /PRNewswire/ -- The HERO ESPORTS Asian Champions League (ACL), Asia's premier multi-title esports tournament hosted by Hero Esports, has announced the addition of Street Fighter 6 to its inaugural lineup. Notably, the ACL...

Court Rules Voting Rights Restriction on Young Poong as Unlawful

Court Rules Voting Rights Restriction on Young Poong as Unlawful

Most Resolutions from Korea Zinc's Extraordinary Shareholders' Meeting Suspended… A Big Win for Young Poong and MBK Partners A Green Light for Securing Control Over Korea Zinc SEOUL, South Korea, March 8, 2025 /PRNewswire/ -- The court has ruled...

HERO ESPORTS Asian Champions League: Dota 2 Tournament Champions Secure Place in Esports World Cup

HERO ESPORTS Asian Champions League: Dota 2 Tournament Champions Secure Place in Esports World Cup

SHANGHAI, March 7, 2025 /PRNewswire/ -- The HERO ESPORTS Asian Champions League (ACL), Asia's premier multi-title esports tournament hosted by Asia's leading esports company Hero Esports, announced that champions of the ACL Dota 2 Tournament will...

Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics

Brexogen and BMI Korea Enter Strategic Technology Transfer Agreement for Exosome Therapeutics

Out-licenses BxC-I17e, Exosome-Based Therapeutics for New Indications KRW 3 Billion Non-Refundable Upfront Payment + Milestone Payments + Double-Digit Percentage Royalties SEOUL, South Korea, Feb. 19, 2025 /PRNewswire/ -- Brexogen, a leading...

  • 1
  • 2
  • menu
    menu